' '
Deutsch | English    

Forschungsdatenbank PMU-SQQUID


Gewähltes Keyword: Hypoallergen

Synergistic effects of dendritic cell targeting and laser-microporation on enhancing epicutaneous skin vaccination efficacy.
Machado, Y; Duinkerken, S; Hoepflinger, V; Mayr, M; Korotchenko, E; Kurtaj, A; Pablos, I; Steiner, M; Stoecklinger, A; Lübbers, J; Schmid, M; Ritter, U; Scheiblhofer, S; Ablinger, M; Wally, V; Hochmann, S; Raninger, AM; Strunk, D; van Kooyk, Y; Thalhamer, J; Weiss, R;
J Control Release. 2017; 266: 87-99.
Originalarbeiten (Zeitschrift)
The Evolution of Human Basophil Biology from Neglect towards Understanding of Their Immune Functions.
Steiner, M; Huber, S; Harrer, A; Himly, M;
Biomed Res Int. 2016; 2016: 8232830
Molecular approach to allergy diagnosis and therapy.
Ferreira, F; Wolf, M; Wallner, M;
Yonsei Med J. 2014; 55(4): 839-852.
Feeding patterns during the first 2 years and health outcome.
Haschke, F; Haiden, N; Detzel, P; Yarnoff, B; Allaire, B; Haschke-Becher, E
Ann Nutr Metab. 2013; 62 Suppl 3:16-25
Originalarbeiten (Zeitschrift)
Designing hypoallergenic derivatives for allergy treatment by means of in silico mutation and screening.
Thalhamer, T; Dobias, H; Stepanoska, T; Pröll, M; Stutz, H; Dissertori, O; Lackner, P; Ferreira, F; Wallner, M; Thalhamer, J; Hartl, A;
J Allergy Clin Immunol. 2010; 125(4):926-934.e10
Originalarbeiten (Zeitschrift)
Antigen aggregation decides the fate of the allergic immune response.
Zaborsky, N; Brunner, M; Wallner, M; Himly, M; Karl, T; Schwarzenbacher, R; Ferreira, F; Achatz, G
J IMMUNOL. 2010; 184(2): 72-35.
Originalarbeiten (Zeitschrift)
Allergy multivaccines created by DNA shuffling of tree pollen allergens.
Wallner, M; Stöcklinger, A; Thalhamer, T; Bohle, B; Vogel, L; Briza, P; Breiteneder, H; Vieths, S; Hartl, A; Mari, A; Ebner, C; Lackner, P; Hammerl, P; Thalhamer, J; Ferreira, F;
J Allergy Clin Immunol. 2007; 120(2):374-380
Originalarbeiten (Zeitschrift)
Generation of hypoallergenic DNA vaccines by forced ubiquitination: preventive and therapeutic effects in a mouse model of allergy.
Bauer, R; Scheiblhofer, S; Kern, K; Gruber, C; Stepanoska, T; Thalhamer, T; Hauser-Kronberger, C; Alinger, B; Zoegg, T; Gabler, M; Ferreira, F; Hartl, A; Thalhamer, J; Weiss, R;
J Allergy Clin Immunol. 2006; 118(1):269-276
Originalarbeiten (Zeitschrift)
Non-anaphylactic surface-exposed peptides of the major birch pollen allergen, Bet v 1, for preventive vaccination.
Focke, M; Linhart, B; Hartl, A; Wiedermann, U; Sperr, WR; Valent, P; Thalhamer, J; Kraft, D; Valenta, R;
Clin Exp Allergy. 2004; 34(10):1525-1533
Originalarbeiten (Zeitschrift)
Vaccines for birch pollen allergy based on genetically engineered hypoallergenic derivatives of the major birch pollen allergen, Bet v 1
Mahler, V; Vrtala, S; Kuss, O; Diepgen, TL; Suck, R; Cromwell, O; Fiebig, H; Hartl, A; Thalhamer, J; Schuler, G; Kraft, D; Valenta, R
CLIN EXP ALLERGY. 2004; 34(1): 115-122.
Originalarbeiten (Zeitschrift)
Strategies for the development of safe and effective DNA vaccines for allergy treatment.
Hartl, A; Weiss, R; Hochreiter, R; Scheiblhofer, S; Bauer, R; Valenta, R; Ferreira, F; Leitner, W; Thalhamer, J;
Arb Paul Ehrlich Inst Bundesamt Sera Impfstoffe Frankf A M. 2003; 27-98
Prevention of allergen-specific IgE production and suppression of an established Th2-type response by immunization with DNA encoding hypoallergenic allergen derivatives of Bet v 1, the major birch-pollen allergen.
Hochreiter, R; Stepanoska, T; Ferreira, F; Valenta, R; Vrtala, S; Thalhamer, J; Hartl, A;
Eur J Immunol. 2003; 33(6):1-76
Originalarbeiten (Zeitschrift)
Genetic engineering of allergens: future therapeutic products.
Ferreira, F; Wallner, M; Breiteneder, H; Hartl, A; Thalhamer, J; Ebner, C;
Int Arch Allergy Immunol. 2002; 128(3): 171-178.